Post job

NeoGenomics Laboratories CEO and executives

Executive Summary. Based on our data team's research, Lynn A. Tetrault - Executive Chair is the NeoGenomics Laboratories's CEO. NeoGenomics Laboratories has 1,500 employees, of which 60 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The NeoGenomics Laboratories executive team is 33% female and 67% male.
  • 62% of the management team is White.
  • 9% of NeoGenomics Laboratories management is Hispanic or Latino.
  • 12% of the management team is Black or African American.
Work at NeoGenomics Laboratories?
Share your experience

Rate NeoGenomics Laboratories' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Lynn A. Tetrault - Executive Chair

Chairman & Chief Executive Officer

Michael Dent

Founder

Sujata Chakraborty

Board Member

Kathryn B. McKenzie

Chief Sustainability and Risk Officer

Kathryn B. McKenzie's LinkedIn

Kathryn McKenzie is a Chief Financial Officer at NEOGENOMICS INC and is based in New Orleans, Louisiana. She has worked as VP, Chief Accounting Officer at NEOGENOMICS INC; Assistant Controller at Chico's; and SEC Reporting and Treasury at Chico's. Kathryn attended University of North Carolina Wilmington.

Jennifer M. Balliet

VP/Chief Culture Officer

Mrs. Balliet joined NeoGenomics in 2008 as Director, Human Resources. Since then, she has been appointed as Vice President, Human Resources in 2015 and Chief Culture Officer in 2016. Mrs. Balliet has managed Human Resources as the Company grew from 100 employees to more than 900 employees. She is responsible for all areas of Human Resources, including recruiting, training, compensation, incentive plans, and organizational development. Mrs. Balliet received her Bachelor of Science degree in Psychology and her Master of Science degree in Business Management from the University of Florida.

Marcus B. Silva Jd, Mba

Chief Marketing Officer

Marcus B. Silva Jd, Mba's LinkedIn

Healthcare executive with the proven ability to lead strategy development, build winning teams and create a results driven culture at the intersection of pharmaceuticals, medical devices and diagnostics and healthcare delivery. Entrepreneurial, Strategic and Creative Marketing Leader with proven ability to identify insights, develop innovative strategies that capitalize on business dynamics to support profitable growth, and create “first-ever” opportunities in a fast-paced, ever changing environment. Agile learner and leader with a track record of quickly learning new industries and therapeutic areas to drive results in start-up companies and Fortune 500 brands, such as Johnson & Johnson, Becton Dickinson and Novartis Pharmaceuticals.

William Bishop Bonello

Chief Financial Officer

William Bishop Bonello's LinkedIn

Bill Bonello is an Analyst at Craig-Hallum Capital Group and Chief Strategy Officer at NEOGENOMICS INC and is based in Minnesota. He has worked as analyst at Piper Jaffray Companies.

Alison L. Hannah

Board Member

Bruce K. Crowther

Board Member

David J. Daly

Board Member

Do you work at NeoGenomics Laboratories?

Does leadership effectively guide NeoGenomics Laboratories toward its goals?

NeoGenomics Laboratories jobs

NeoGenomics Laboratories founders

Name & TitleBio
Michael Dent

Founder

NeoGenomics Laboratories board members

Name & TitleBio
Lynn A. Tetrault - Executive Chair

Chairman & Chief Executive Officer

Sujata Chakraborty

Board Member

Jennifer M. Balliet

VP/Chief Culture Officer

Mrs. Balliet joined NeoGenomics in 2008 as Director, Human Resources. Since then, she has been appointed as Vice President, Human Resources in 2015 and Chief Culture Officer in 2016. Mrs. Balliet has managed Human Resources as the Company grew from 100 employees to more than 900 employees. She is responsible for all areas of Human Resources, including recruiting, training, compensation, incentive plans, and organizational development. Mrs. Balliet received her Bachelor of Science degree in Psychology and her Master of Science degree in Business Management from the University of Florida.

Alison L. Hannah

Board Member

Bruce K. Crowther

Board Member

David J. Daly

Board Member

Michael Anthony Kelly

Board Member

Rachel A. Stahler

Board Member

Stephen M. Kanovsky

Board Member

Steven G. Brodie

Board Member

Steven Brodie is a VP:Operations at NEOGENOMICS INC, Chief Scientific Officer at NEOGENOMICS INC, and President:Pharma Services at NEOGENOMICS INC. He has worked as Dir:Fort Myers FL LAB at NEOGENOMICS INC, Rotation Director at Loma Linda University Medical Center, and Dir:Molecular Genetics & Cytogenetics at NEOGENOMICS INC. Steven studied at University of New Mexico School of Medicine.

NeoGenomics Laboratories leadership demographics

NeoGenomics Laboratories gender distribution in management team

  • The NeoGenomics Laboratories executive team is 33% female and 67% male.
  • NeoGenomics Laboratories is 57% female and 43% male company-wide.
Male
Male
67%
Company-wide: 43%
Female
Female
33%
Company-wide: 57%

NeoGenomics Laboratories executives by race

Management Team:
  • The most common ethnicity among NeoGenomics Laboratories executive officers is White.
  • 62% of the management team is White.
  • 14% of NeoGenomics Laboratories's management is Asian.
  • 12% of the management team is Black or African American.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 55% of employees are White.
  • 22% of employees are Hispanic or Latino.
  • 11% of employees are Black or African American.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

NeoGenomics Laboratories jobs nearby

NeoGenomics Laboratories executives FAQs

Zippia gives an in-depth look into the details of NeoGenomics Laboratories, including salaries, political affiliations, employee data, and more, in order to inform job seekers about NeoGenomics Laboratories. The employee data is based on information from people who have self-reported their past or current employments at NeoGenomics Laboratories. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by NeoGenomics Laboratories. The data presented on this page does not represent the view of NeoGenomics Laboratories and its employees or that of Zippia.

NeoGenomics Laboratories may also be known as or be related to NEOGENOMICS INC, NeoGenomics, NeoGenomics Inc, NeoGenomics Laboratories, NeoGenomics Laboratories, Inc., NeoGenomics, Inc., Neogenomics Laboratories and Neogenomics, Inc.